FDA Panel Likes New Abuse-Deterrent Opioid http://www.medpagetoday.com/Neurology/PainManagement/53528?xid=nl_mpt_DHE_2015-09-14&eun=g578717d0r WASHINGTON — In a second joint meeting of two FDA advisory committees, all 23 panelists voted unanimously to approve an abuse-deterrent formulation of extended-release oxycodone (Xtampza). Panelists felt that the new formulation, which is comprised of tiny microspheres of drug collected inside a capsule, would pose a significant […]
Filed under: General Problems | 1 Comment »